Robert Alexander Ingram, Director at OSI PHARMACEUTICALS INC (OSIP), sold 49,700 shares at $32.59 ($1.6M) on 2007-03-27, disclosed to the SEC on 2007-03-29.
Open-market sale of $1.6M OSIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.21 | 1,000 | $32K | 2.0% |
| 2 | $32.23 | 400 | $13K | 0.8% |
| 3 | $32.24 | 1,000 | $32K | 2.0% |
| 4 | $32.25 | 1,600 | $52K | 3.2% |
| 5 | $32.26 | 3,400 | $110K | 6.8% |
| 6 | $32.27 | 4,400 |
| $142K |
| 8.8% |
| 7 | $32.28 | 3,240 | $105K | 6.5% |
| 8 | $32.29 | 3,060 | $99K | 6.1% |
| 9 | $32.30 | 1,600 | $52K | 3.2% |
| 10 | $32.31 | 2,200 | $71K | 4.4% |
| 11 | $32.32 | 1,200 | $39K | 2.4% |
| 12 | $32.33 | 100 | $3K | 0.2% |
| 13 | $32.34 | 500 | $16K | 1.0% |
| 14 | $32.35 | 400 | $13K | 0.8% |
| 15 | $32.36 | 100 | $3K | 0.2% |
| 16 | $32.37 | 1,600 | $52K | 3.2% |
| 17 | $32.39 | 800 | $26K | 1.6% |
| 18 | $32.40 | 900 | $29K | 1.8% |
| 19 | $32.50 | 3,600 | $117K | 7.3% |
| 20 | $32.51 | 300 | $10K | 0.6% |
| 21 | $32.53 | 3,100 | $101K | 6.3% |
| 22 | $32.54 | 2,000 | $65K | 4.0% |
| 23 | $32.55 | 900 | $29K | 1.8% |
| 24 | $32.56 | 700 | $23K | 1.4% |
| 25 | $32.57 | 5,891 | $192K | 11.9% |
| 26 | $32.58 | 2,742 | $89K | 5.5% |
| 27 | $32.59 | 2,109 | $69K | 4.3% |
| 28 | $32.60 | 758 | $25K | 1.5% |
| 29 | $32.63 | 100 | $3K | 0.2% |
| Total | $32.41 avg | 49,700 | $1.6M | 100% |
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |